Association between Patient-Reported Social Determinant of Health Outcomes and a Social Genomics Profile in Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis
Mallory Taylor(Center for Cancer and Blood Disorders), Jennifer M. Knight(Medical College of Wisconsin), Joelle Strom(Medical College of Wisconsin), K. Scott Baker(Malaria Consortium), Betty K. Hamilton(Cleveland Clinic), David Buchbinder(Children's Hospital of Orange County), Ruta Brazauskas(Medical College of Wisconsin), Hélène Schoemans(KU Leuven), Rachel Phelan(Children's Hospital of Wisconsin), Steve W. Cole(APLA Health)
Cited by 0
Related Papers
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718
EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
|Bone Marrow Transplantation|2018|479
Human Social Genomics
|PLoS Genetics|2014|411